713 related articles for article (PubMed ID: 11890901)
1. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
Cai Z; Lin S; Rhodes PG
Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
Thomas AG; Olkowski JL; Slusher BS
Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
[TBL] [Abstract][Full Text] [Related]
3. N-acetyl-aspartyl-glutamate and inhibition of glutamate carboxypeptidases protects against soman-induced neuropathology.
Guo H; Liu J; Van Shura K; Chen H; Flora MN; Myers TM; McDonough JH; McCabe JT
Neurotoxicology; 2015 May; 48():180-91. PubMed ID: 25825357
[TBL] [Abstract][Full Text] [Related]
4. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin.
Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS
J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.
Slusher BS; Vornov JJ; Thomas AG; Hurn PD; Harukuni I; Bhardwaj A; Traystman RJ; Robinson MB; Britton P; Lu XC; Tortella FC; Wozniak KM; Yudkoff M; Potter BM; Jackson PF
Nat Med; 1999 Dec; 5(12):1396-402. PubMed ID: 10581082
[TBL] [Abstract][Full Text] [Related]
6. Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist.
Cai Z; Xiao F; Fratkin JD; Rhodes PG
Neuroreport; 1999 Dec; 10(18):3927-31. PubMed ID: 10716235
[TBL] [Abstract][Full Text] [Related]
7. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons.
Tortella FC; Lin Y; Ved H; Slusher BS; Dave JR
Eur J Pharmacol; 2000 Aug; 402(1-2):31-7. PubMed ID: 10940354
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism.
Xi ZX; Li X; Peng XQ; Li J; Chun L; Gardner EL; Thomas AG; Slusher BS; Ashby CR
J Neurochem; 2010 Jan; 112(2):564-76. PubMed ID: 19895667
[TBL] [Abstract][Full Text] [Related]
10. N-acetylaspartylglutamate protects against transient focal cerebral ischemia in rats.
Lu XM; Tang Z; Liu W; Lin Q; Slusher BS
Eur J Pharmacol; 2000 Nov; 408(3):233-9. PubMed ID: 11090639
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide hydrolysis in vivo with group I metabotropic glutamate receptor agonists.
Johnson MP; Chamberlain M; Kelly GM
Brain Res; 1999 Mar; 821(2):539-45. PubMed ID: 10064844
[TBL] [Abstract][Full Text] [Related]
13. Blockade of NAALADase: a novel neuroprotective strategy based on limiting glutamate and elevating NAAG.
Vornov JJ; Wozniak K; Lu M; Jackson P; Tsukamoto T; Wang E; Slusher B
Ann N Y Acad Sci; 1999; 890():400-5. PubMed ID: 10668445
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with mGluR2 or mGluR3 Agonists Reduces Apoptosis Induced by Hypoxia-Ischemia in Neonatal Rat Brains.
Bratek-Gerej E; Bronisz A; Ziembowicz A; Salinska E
Oxid Med Cell Longev; 2021; 2021():8848015. PubMed ID: 33763176
[TBL] [Abstract][Full Text] [Related]
15. The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity.
Fitzjohn SM; Bortolotto ZA; Palmer MJ; Doherty AJ; Ornstein PL; Schoepp DD; Kingston AE; Lodge D; Collingridge GL
Neuropharmacology; 1998 Dec; 37(12):1445-58. PubMed ID: 9886667
[TBL] [Abstract][Full Text] [Related]
16. N-acetylaspartylglutamate and beta-NAAG protect against injury induced by NMDA and hypoxia in primary spinal cord cultures.
Yourick DL; Koenig ML; Durden AV; Long JB
Brain Res; 2003 Nov; 991(1-2):56-64. PubMed ID: 14575876
[TBL] [Abstract][Full Text] [Related]
17. GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.
Sanabria ER; Wozniak KM; Slusher BS; Keller A
J Neurophysiol; 2004 Jan; 91(1):182-93. PubMed ID: 12917384
[TBL] [Abstract][Full Text] [Related]
18. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.
Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W
Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034
[TBL] [Abstract][Full Text] [Related]
19. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.
Zhong C; Zhao X; Van KC; Bzdega T; Smyth A; Zhou J; Kozikowski AP; Jiang J; O'Connor WT; Berman RF; Neale JH; Lyeth BG
J Neurochem; 2006 May; 97(4):1015-25. PubMed ID: 16606367
[TBL] [Abstract][Full Text] [Related]
20. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
Lea PM; Wroblewska B; Sarvey JM; Neale JH
J Neurophysiol; 2001 Mar; 85(3):1097-106. PubMed ID: 11247980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
